ClinConnect ClinConnect Logo
Search / Trial NCT07065474

Effectiveness of Edutainment-Based Interventions in Increasing Knowledge of Rheumatic Fever and Rheumatic Heart Disease Among School-Going Children in Nepal: Study Protocol for Colors to Save Hearts Quasi-Experimental Pretest-Posttest Study

Launched by KATHMANDU INSTITUTE OF CHILD HEALTH · Jul 13, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Colour To Save Hearts Rheumatic Heart Disease Rheumatic Fever Health Awarness Youth Intervention

ClinConnect Summary

This study is looking at a new way to help school children in Nepal learn about rheumatic fever and rheumatic heart disease—illnesses that affect the heart and can be prevented if caught early. The researchers want to see if using fun and creative tools like coloring books, stories, videos, and interactive activities can improve children’s understanding of these diseases. The study will involve around 2,400 students in grades 6 to 9 from 24 public schools across different parts of Nepal.

If your child is in one of these schools and in the right grade, they might be invited to join. Participation is voluntary, and consent from parents or guardians is required. Children will be asked to complete a simple questionnaire before and after the activities to see how much they have learned. The study will also check for any signs of heart-related problems in the children. The goal is to find an engaging way to educate kids about these preventable diseases and possibly include these fun learning methods in schools across Nepal in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Students will be eligible for inclusion in the study if they are formally enrolled in one of the selected public schools and are studying in grades 6 to 9 during implementation of this study.
  • Exclusion Criteria:
  • Students will be excluded from the study if they or their guardians decline to participate or fail to provide the required consent and assent. Students who are absent during both the baseline and post-intervention assessments will also be excluded from the final analysis.

About Kathmandu Institute Of Child Health

The Kathmandu Institute of Child Health is a leading healthcare and research organization dedicated to advancing pediatric medicine and improving child health outcomes. Committed to excellence in clinical care, education, and innovative research, the institute focuses on developing evidence-based interventions and therapies to address a wide range of childhood illnesses and conditions. Through collaborative clinical trials and community engagement, it aims to enhance the quality of life for children locally and globally.

Locations

Kathmandu, Bagmati, Nepal

Patients applied

0 patients applied

Trial Officials

Dr. Sandeepa Karki, MD Community Medicine

Principal Investigator

Kathmandu Institute of Child Health

Mr. Dhurba Khatri, MPH

Principal Investigator

Kathmandu Institute of Child Health

Mr. Shishir Paudel, MPH

Principal Investigator

Kathmandu Institute of Child Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported